149 related articles for article (PubMed ID: 35068266)
1. Antipsychotic treatment patterns in Alzheimer's disease patients with agitation: a cohort study using the UK clinical practice research datalink.
Tran CT; Bøg M; Collings SL; Johnson M; Qizilbash N; Lind S; Baker RA; Jørgensen KT
Curr Med Res Opin; 2022 Mar; 38(3):409-416. PubMed ID: 35068266
[TBL] [Abstract][Full Text] [Related]
2. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
3. Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.
Panza F; Solfrizzi V; Seripa D; Imbimbo BP; Santamato A; Lozupone M; Prete C; Greco A; Pilotto A; Logroscino G
Expert Opin Pharmacother; 2015; 16(17):2581-8. PubMed ID: 26389682
[TBL] [Abstract][Full Text] [Related]
4. A 2023 update on the advancements in the treatment of agitation in Alzheimer's disease.
Lee D; Clark ED; Antonsdottir IM; Porsteinsson AP
Expert Opin Pharmacother; 2023 Apr; 24(6):691-703. PubMed ID: 36958727
[TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
6. An update on the advancements in the treatment of agitation in Alzheimer's disease.
Porsteinsson AP; Antonsdottir IM
Expert Opin Pharmacother; 2017 Apr; 18(6):611-620. PubMed ID: 28300462
[TBL] [Abstract][Full Text] [Related]
7. A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease.
Kirbach S; Simpson K; Nietert PJ; Mintzer J
Clin Drug Investig; 2008; 28(5):291-303. PubMed ID: 18407715
[TBL] [Abstract][Full Text] [Related]
8. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
Ballard C; Thomas A; Gerry S; Yu LM; Aarsland D; Merritt C; Corbett A; Davison C; Sharma N; Khan Z; Creese B; Loughlin P; Bannister C; Burns A; Win SN; Walker Z;
J Am Med Dir Assoc; 2015 Apr; 16(4):316-22. PubMed ID: 25523285
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments.
Liu CS; Ruthirakuhan M; Chau SA; Herrmann N; Carvalho AF; Lanctôt KL
Curr Alzheimer Res; 2016; 13(10):1134-44. PubMed ID: 27137221
[TBL] [Abstract][Full Text] [Related]
10. When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram.
Aga VM
Am J Geriatr Psychiatry; 2019 Oct; 27(10):1099-1107. PubMed ID: 31288974
[TBL] [Abstract][Full Text] [Related]
11. Clinical Pipelines for Alzheimer's Disease Psychosis and Agitation.
Oguma T; Jino K
Chem Pharm Bull (Tokyo); 2024; 72(7):610-617. PubMed ID: 38945937
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study.
Nagata T; Nakajima S; Shinagawa S; Plitman E; Graff-Guerrero A; Mimura M; Nakayama K
Int J Geriatr Psychiatry; 2017 Dec; 32(12):1264-1271. PubMed ID: 27714849
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C Study.
De Mauleon A; Delrieu J; Cantet C; Vellas B; Andrieu S; Rosenberg PB; Lyketsos CG; Soto Martin M
J Prev Alzheimers Dis; 2021; 8(2):199-209. PubMed ID: 33569568
[TBL] [Abstract][Full Text] [Related]
14. Use of psychotropic agents to treat agitation and aggression in Brazilian patients with Alzheimer's disease: A naturalistic and multicenter study.
Oliveira LF; Camargos EF; Martini LLL; Machado FV; Novaes MRCG
Psychiatry Res; 2021 Jan; 295():113591. PubMed ID: 33271491
[TBL] [Abstract][Full Text] [Related]
15. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease.
Creese B; Da Silva MV; Johar I; Ballard C
Expert Rev Neurother; 2018 Jun; 18(6):461-467. PubMed ID: 29764230
[TBL] [Abstract][Full Text] [Related]
16. Risks and benefits of current and novel drugs to treat agitation in Alzheimer's disease.
Herrmann N; Wang HJ; Song BX; Bawa KK; Lanctôt KL
Expert Opin Drug Saf; 2022 Oct; 21(10):1289-1301. PubMed ID: 36252087
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.
Tifratene K; Manera V; Fabre R; Gros A; Thummler S; Pradier C; Robert P; David R
Alzheimers Res Ther; 2017 Apr; 9(1):34. PubMed ID: 28446209
[TBL] [Abstract][Full Text] [Related]
18. New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: focus on brexpiprazole and pimavanserin.
Caraci F; Santagati M; Caruso G; Cannavò D; Leggio GM; Salomone S; Drago F
F1000Res; 2020; 9():. PubMed ID: 32695312
[TBL] [Abstract][Full Text] [Related]
19. Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's Disease.
Tao Y; Peters ME; Drye LT; Devanand DP; Mintzer JE; Pollock BG; Porsteinsson AP; Rosenberg PB; Schneider LS; Shade DM; Weintraub D; Yesavage J; Lyketsos CG; Munro CA
Am J Alzheimers Dis Other Demen; 2018 Nov; 33(7):450-457. PubMed ID: 29969907
[TBL] [Abstract][Full Text] [Related]
20. Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial.
Ballard C; Corbett A; Orrell M; Williams G; Moniz-Cook E; Romeo R; Woods B; Garrod L; Testad I; Woodward-Carlton B; Wenborn J; Knapp M; Fossey J
PLoS Med; 2018 Feb; 15(2):e1002500. PubMed ID: 29408901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
